Skip to main content
. 2016 Apr 12;26(4):e12490. doi: 10.1111/ecc.12490

Table 4.

Circumstances of discovery of bone metastases and lesions, by malignancy type and by country: data from the detailed questionnaire

Response given (%) Total (N = 8768) France (n = 1665) Germany (n = 2326) Italy (n = 1680) Spain (n = 1534) UK (n = 1563)
ST HM ST HM ST HM ST HM ST HM ST HM
Staging at diagnosis 38 65 41 74 31 75 39 57 37 52 45 68
Bone pain 35 36 48 52 20 7 34 37 37 46 42 34
Routine metastases screening 25 5 14 2 41 12 30 6 21 7 6 1
Investigation following an eventa 7 18 9 20 5 10 6 23 5 20 9 13
Hypercalcaemia 5 9 6 15 3 1 4 7 5 9 6 13
Accidental discovery 5 3 5 1 5 1 5 3 6 9 4 1
Otherb 3 0 6 0 0 0 3 0 4 0 3 0

HM, haematological malignancy; PSA, prostate‐specific antigen; ST, solid tumour.

a

Events included confirmed or suspected pathologic fracture or spinal compression.

b

Including increase in tumour markers (e.g. PSA), check on spread of metastases/restaging for any metastases, extensive examination after finding lumps, worsening of general condition and pain. Investigators could give more than one response.